weight regain tirzepatide Loss Maintenance Strategies | Dr Meghanath Yenni posted on the topic Direct Link to JAMA Post

While tirzepatide has demonstrated greater average weight loss in several studies, the best treatment option depends on the individual patient

however, tirzepatide outperforms semaglutide due to its dual-pathway action

Those who fall short of this threshold typically remain late responders throughout treatment, achieving lower total weight loss despite continuing the protocol

Your body needs time to adjust to this new receptor stimulation

Eli Lilly offers copay assistance programs to reduce costs, sometimes as low as $25 per month for eligible patients

Below is your insiders cheat sheet, including how each method works, what youll likely pay, who benefits most, and the fine print that could make or break the deal